US Patent Issued to Prelude Therapeutis on Dec. 2 for "CDK inhibitors and their use as pharmaceuticals" (Delaware, Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,277, issued on Dec. 2, was assigned to Prelude Therapeutis Inc. (Wilmington, Del.).

"CDK inhibitors and their use as pharmaceuticals" was invented by Liang Lu (Hockessin, Del.), Rupa Shetty (Blue Bell, Pa.), Andrew Paul Combs (Kennett Square, Pa.), Chaofeng Dai (Hockessin, Del.), Raul Andrew Leal (Newark, Del.) and Klare Lazor Bersch (Glen Mills, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation."

The patent was filed on April 4, 2023, under Application No. 18/295,394.

*For further information,...